Earnings History Data for Synthetic Biologics, Inc (SYN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Synthetic Biologics, Inc
Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan.
Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11-08-2022 | PM | 6:45 AM ET (Aug 11) |
SYN | Synthetic Biologics, Inc | 24.56 | -0.31 | 0.00 | -0.20 | Synthetic Biologics GAAP EPS of -$0.31 [8/11/2022 8:03 AM] |
1.42 | 0.0 (0.00%) |
1.42 | 0.0 (0.00%) |
1.35 - 5.58 | 155,487 | 570,000 | 3,741 | |
16-05-2022 | PM | 6:45 AM ET (May 16) |
SYN | Synthetic Biologics, Inc | 31.69 | -0.03 | 0.00 | -0.13 | Synthetic Biologics GAAP EPS of -$0.03 in-line [5/16/2022 8:05 AM] |
0.2311 | 0.0 (0.92%) |
0.23 | 0.0 (0.44%) |
0.20 - 0.72 | 520,315 | 1,030,000 | 5,585 | |
16-03-2022 | AH | 4:10 PM ET (Mar 16) |
SYN | Synthetic Biologics, Inc | 30.50 | -0.04 | 0.00 | -0.14 | Synthetic Biologics GAAP EPS of -$0.19 misses by $0.01 [3/16/2022 4:08 PM] |
0.3480 | 0.10 (38.04%) |
0.2415 | -0.01 (-4.20%) |
0.22 - 0.85 | 29,488,961 | 1,724,765 | 14,536 | |
03-11-2021 | AH | 4:10 PM ET (Nov 3) |
SYN | Synthetic Biologics, Inc | 57.20 | -0.02 | 0.00 | -0.14 | Synthetic Biologics EPS beats by $0.01 [11/3/2021 4:21 PM] |
0.4301 | 0.0 (-0.55%) |
0.44 | 0.0 (0.58%) |
0.31 - 1.70 | 1,638,200 | 1,870,000 | 103,257 | |
05-08-2021 | AH | 4:10 PM ET (Aug 5) |
SYN | Synthetic Biologics, Inc | 67.10 | -0.02 | 0.00 | -0.18 | Synthetic Biologics EPS in-line [8/5/2021 4:39 PM] |
0.4999 | -0.01 (-1.65%) |
0.51 | 0.0 (-0.06%) |
0.26 - 1.70 | 1,351,394 | 1,520,000 | 27,426 | |
05-05-2021 | AH | 4:10 PM ET (May 5) |
SYN | Synthetic Biologics, Inc | 74.29 | -0.13 | 0.00 | -0.20 | Synthetic Biologics reports Q1 results [5/5/2021 4:16 PM] |
0.4598 | -0.05 (-9.09%) |
0.46 | 0.0 (0.26%) |
0.25 - 1.70 | 4,259,211 | 2,960,000 | 3,469 | |
04-03-2021 | AH | 4:10 PM ET (Mar 4) |
SYN | Synthetic Biologics, Inc | 48.34 | -0.14 | 0.00 | -0.19 | Synthetic Biologics EPS misses by $0.10 [3/4/2021 4:14 PM] |
0.5591 | -0.02 (-3.62%) |
0.5680 | -0.01 (-2.09%) |
0.25 - 1.70 | 16,189,042 | 16,262,781 | 1,007,024 | |
10-11-2020 | AH | 4:10 PM ET (Nov 10) |
SYN | Synthetic Biologics, Inc | 6.80 | -0.14 | 0.00 | -0.31 | Synthetic Biologics EPS beats by $0.03 [11/10/2020 4:18 PM] |
0.3419 | 0.0 (-0.03%) |
0.3333 | -0.01 (-2.54%) |
0.25 - 0.75 | 249,202 | 331,192 | 6,101 | |
|